Shares of Novus Therapeutics were on a downward spiral on Monday, losing almost half of their value after the specialty drug maker announced disappointing trial results of its ear infection treatment OP0201. Novus revealaed that a phase 2a trial of OP0201 in acute otitis media did not achieve statistical significance in achieving its primary targets … Continue reading “Novus Therapeutics Plummets After Disappointing Drug Trial Results”
Biotech & Pharma
Biotech & Pharma
Arca Biopharma Explodes Higher After Announcing Plans to Test a Coronavirus Drug
Shares of Arca Biopharma were skyrocketing on Thursday and nearly quintupled in value after the…
May 29, 2020
Biotech & Pharma
Amgen and Alexion Pharmaceuticals Reach Agreement in Patent Battle
Shares of Alexion Pharmaceuticals were soaring on Thursday and Friday after the company along with…
May 29, 2020
Biotech & Pharma
Moderna Shares Soar on Positive Results on Early Stage Coronavirus Vaccine Trial
Shares of Moderna were surging in Monday's trading session after the company revealed positive data…
May 19, 2020
Biotech & Pharma
Pfizer is Planning to Test Coronavirus Vaccine on Thousands of People
With the coronavirus pandemic still going and with no end in sight, drug makers are…
May 14, 2020
Biotech & Pharma
Crispr Therapeutics Explodes 15% After New Blood Disease Drug Gets Fast-Track
Shares of Crispr Therapeutics were on the rise since Monday, shooting up almost 15% after…
May 14, 2020
Biotech & Pharma
Mylan CEO Says Company Had “Minimal Disruption” During Coronavirus Pandemic
According to Mylan CEO Heather Bresch, the company's global supply chain has helped it experience…
May 12, 2020
Biotech & Pharma
FDA is in Discussions with Gilead to Make Remdesivir Available As Quickly as Possible
At the rate of how many are being infected with coronavirus and how many are…
April 29, 2020
Biotech & Pharma
Biogen Tumbles After Delay of Alzheimer’s Treatment Submission
Shares of biotech giant Biogen were falling on Wednesday after the company said it would…
April 23, 2020
Biotech & Pharma
Gilead Sciences Gets a Downgrade from BMO Capital and Wells Fargo
Shares of Gilead Sciences were downgraded on Monday by not one but two firms, BMO…
April 20, 2020
Biotech & Pharma
Abbott Gets Approval for a Coronavirus Test that Can Get Results in 5 Minutes
One of the biggest issues with the coronavirus pandemic is that there are not enough…
March 30, 2020
Biotech & Pharma
A Japanese Flu Drug May Be Able to Treat Coronavirus
According to an NHK report, there is a Japanese flu drug that could be effective…
March 19, 2020
Biotech & Pharma
Revolution Medicines Inc. Explodes on First Day of Trading
Clinical stage oncology company Revolution Medicines, Inc. made its debut in the stock market on…
February 14, 2020
Biotech & Pharma
Aimmune Shares Explode on Peanut Allergy Treatment Approval from FDA
Aimmune Therapeutics saw its shares flying on Monday after the company gained Food and Drug…
February 3, 2020